DE59405654D1 - T-LYMPHOCYTE-CONTAINING PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF INFECTIONS - Google Patents

T-LYMPHOCYTE-CONTAINING PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF INFECTIONS

Info

Publication number
DE59405654D1
DE59405654D1 DE59405654T DE59405654T DE59405654D1 DE 59405654 D1 DE59405654 D1 DE 59405654D1 DE 59405654 T DE59405654 T DE 59405654T DE 59405654 T DE59405654 T DE 59405654T DE 59405654 D1 DE59405654 D1 DE 59405654D1
Authority
DE
Germany
Prior art keywords
lymphocyte
infections
treatment
pharmaceutical composition
containing pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE59405654T
Other languages
German (de)
Inventor
Bernhard Heising
Edelgard Heising
Franziska Heising
Cathrin Heising
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority claimed from PCT/EP1994/002313 external-priority patent/WO1995003812A1/en
Application granted granted Critical
Publication of DE59405654D1 publication Critical patent/DE59405654D1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
    • A61K39/464838—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/461—Cellular immunotherapy characterised by the cell type used
    • A61K39/4611—T-cells, e.g. tumor infiltrating lymphocytes [TIL], lymphokine-activated killer cells [LAK] or regulatory T cells [Treg]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
    • A61K39/4648—Bacterial antigens
DE59405654T 1993-07-29 1994-07-13 T-LYMPHOCYTE-CONTAINING PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF INFECTIONS Expired - Fee Related DE59405654D1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE4325959 1993-07-29
DE4422020A DE4422020A1 (en) 1993-07-29 1994-06-16 Pharmaceutical composition
PCT/EP1994/002313 WO1995003812A1 (en) 1993-07-29 1994-07-13 T-lymphocyte-containing pharmaceutical composition for treating infections

Publications (1)

Publication Number Publication Date
DE59405654D1 true DE59405654D1 (en) 1998-05-14

Family

ID=6494314

Family Applications (2)

Application Number Title Priority Date Filing Date
DE4422020A Withdrawn DE4422020A1 (en) 1993-07-29 1994-06-16 Pharmaceutical composition
DE59405654T Expired - Fee Related DE59405654D1 (en) 1993-07-29 1994-07-13 T-LYMPHOCYTE-CONTAINING PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF INFECTIONS

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE4422020A Withdrawn DE4422020A1 (en) 1993-07-29 1994-06-16 Pharmaceutical composition

Country Status (1)

Country Link
DE (2) DE4422020A1 (en)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4256588A (en) * 1979-11-02 1981-03-17 E. I. Du Pont De Nemours And Company Separation and recovery of B and T lymphocytes
JPS5936963B2 (en) * 1981-03-10 1984-09-06 旭化成株式会社 T cell isolation material and isolation method
JPS60231613A (en) * 1984-04-28 1985-11-18 Terumo Corp Method for separating humoral component, separation material and separation apparatus therefor
US5106746A (en) * 1985-05-22 1992-04-21 E. I. Du Pont De Nemours And Company Process for the in vitro immunization of human splenocytes against tumor associated antigens
ATE107861T1 (en) * 1986-09-19 1994-07-15 Oncogen USE OF ACTIVATED T-LYMPHOCYTES TO PREPARE A PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF AIDS.
JPH06500023A (en) * 1991-05-16 1994-01-06 イーデーテー　アーゲー　フュア　イン　ビーフォ　ディアグノスティーク　ウント　テラピー Method of providing antigen-specific B and T lymphocytes and monoclonal antibodies obtained therefrom

Also Published As

Publication number Publication date
DE4422020A1 (en) 1995-02-02

Similar Documents

Publication Publication Date Title
DE122009000012I1 (en) Substituted pyrazolylbenzenesulfonamides for the treatment of inflammation.
ATE447947T1 (en) PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF INSULINRESIENCE
DE69332732D1 (en) Pharmaceutical composition and method for the treatment of hyperlipidemia and arteriosclerosis
DE69412552T2 (en) Medical instrument for the treatment of sinusitis
MX9202839A (en) 4-AMINOKINOLINS AND PHARMACEUTICAL COMPOSITIONS OF THE SAME.
DE69710095T2 (en) PHARMACEUTICAL PREPARATION FOR TREATING DIABETES
BR9407799A (en) Composition of matter treatment method and pharmaceutical composition
DE50206657D1 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF MULTIPLE SCLEROSIS
ATE265857T1 (en) PHARMACEUTICAL OR DIETETIC COMPOSITION FOR THE PREVENTION OR TREATMENT OF HYPEROXALUria
ATE256463T1 (en) PHARMACEUTICAL PREPARATION FOR USE IN THE TREATMENT OF DIABETES
DE4497905T1 (en) Pharmaceutical composition for the prevention and treatment of motion sickness syndrome
DE3884200D1 (en) Procedures for the treatment of mastitis and other staph infections.
DE69420229D1 (en) Pharmaceutical composition for the treatment of AIDS
DE69405919D1 (en) Compositions for the treatment of keratin fibers
DE69620691D1 (en) Therapeutic agent for the treatment of hypercholesterolemia
DE69737067D1 (en) VACCINE FOR THE TREATMENT OF MYCOSES
DE69838785D1 (en) PHARMACEUTICAL AGENTS FOR THE TREATMENT OF CEREBRAL AMYLOIDOSIS
DE69834937D1 (en) ANTIBIOTICS FOR THE TREATMENT OF STOMACHES
NO934832D0 (en) Pharmaceutical composition for the prevention or treatment of arterioscerosis
FI965114A0 (en) Pharmaceutical composition for the prevention and / or treatment of viral infections and, optionally, inflammation and method of their treatment
BR9610851A (en) Compound compound preparation process medicine pharmaceutical composition and use of the compound
DE69412178D1 (en) Device for the treatment of layers
DE69408394D1 (en) 4-piperidino-piperidine for the treatment of tumors
NO982562D0 (en) Composition for the treatment of pain
DE68905076D1 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF SKIN Wounds.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8321 Willingness to grant licences paragraph 23 withdrawn
8320 Willingness to grant licences declared (paragraph 23)
8339 Ceased/non-payment of the annual fee
8370 Indication related to discontinuation of the patent is to be deleted
8339 Ceased/non-payment of the annual fee